Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Test Conducted by Test Type & Product The global kidney function test market will witness a robust CAGR of 6.63%, valued at $828.57 million in 2021, expected to appreciate and reach $1476.53 million by 2030, confirms Strategic Market Research. The rapid rising of the global industry is primarily attributed to some the factors like rising prevalence of hypertension and type-2 diabetes, rising prevalence of kidney disease, fast growth in the geriatric population of the country, and the rise of alcohol consumption is increasing the overall development of the market. According to a study advertised in medRXiv in Apr2020, COVID-19 urinary incontinence was commonly found in patients with many infectious and harmful diseases. In the age group of 0 to 12, exposure to the urinary tract COVID-19 has been detected among those who suffer from a little lite form of COVID-19. Urinary tract infections of COVID-19 were detected from day 1 to day 52 after the onset of the disease. Kidney function markers are used to determine how well the kidneys are working. There are both radioactive and non-radioactive indicators. They show the kidneys' glomerular filtration rate and their concentrating and diluting capacity (tubular function). Many people prefer to buy kidney function test over the counter than online. Kidney biopsy is a method that helps doctors identify the cause of kidney problems. Market Drivers The National Kidney Foundation (NKF) and CVS Kidney Care, a Kidney Function test CVS is a Health brand have teamed up to launch a national campaign to increase awareness of kidney disease which affects over 37 million people in the United States. This, in turn, is driving the overall efficacy of the market extensively. Furthermore, one out of every three individuals in the United States, or 33%, is at risk of getting this life-threatening disease. Moreover, due to the increase in privileges of kidney function tests at home, and theorising Research & Development initiatives for the overall growth of the novel products are prevised to boost the entire kidney function test market growth significantly throughout the forecasted period. Market Restraints The high cost of kidney disease diagnosis procedures and authoritarian synchronization are the key factors which are anticipated to hamper the market’s rise. Market Opportunities Several public-private firms are undertaking initiatives to smoothen the overall process of kidney disease testing for the country’s welfare. For example, in July 2020, the National Kidney Foundation (NKF) merged with the National Committee for Quality Assurance (NCQA) to initiate a brand-new kidney health appraisal quantitative, specifically for patients with Type-2 diabetes. The new recommendation proposes a routine test for types-2 Diabetes patients with kidney diseases. Such initiatives are anticipated to generate a remunerative environment for market growth. Kidney Function Test Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 Market size value in 2021 USD 828.57 million Revenue forecast in 2030 USD 1476.53 million Growth rate CAGR of 6.63% The base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation Based By Test Type, Based By Product, Based on End-User, and By region. Based By Test Type Urine Tests, Blood Tests. Based By Product Dipsticks, Reagents, Disposables. By By End-Use Hospitals, Diagnostic Laboratories, Research Laboratories and Institutes, Others. By Region North America, Europe, Asia-Pacific, and LAMEA Country Scope US, Mexico, Canada, Germany, UK, France, China, Japan, India etc. Company Usability Profiles UnititMedical, Sysmex Corporation, Siemens Healthcare GmbH, Hoffmann-La Roche Ltd., Randox Laboratories, Opti Medical, Nova Biomedical, Beckman Coulter, ARKRAY Inc.,Acon Laboratories,Abbott, Cook Medical, 77 Elektronika, Medical Care, Baxter,Boston Scientific. Pricing and purchase options Customized buying options are available to meet your exact research needs. Market Analysis Of Different Segments Covered in the Report Based on Test Type Urine Tests Blood Tests Based on Product: Dipsticks Reagents Disposables Based on End-Use: Hospitals Diagnostic Laboratories Research Laboratories and Institutes Others Regional Coverage Analysis North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Segments Analysis & Insights By Test Type - The market is divided into urine tests and blood tests. Urine protein, Creatinine Test (which usually lies between 0.8 to 1.2 in the normal cases, but it becomes abnormal when it results like kidney function test 3.3, kidney function test 1.6, kidney function test 1.5, kidney function test 1.3, kidney function test 1.4), and microalbumin tests are the three types of urine testing. Blood tests are divided into serum creatinine, glomerular filtration rate (GFR), and blood urea nitrogen (BUN). In 2017, the Kidney function test urine category was predicted to have the most significant market share. This segment is also expected to increase at the fastest CAGR during the projection period. The increasing use of urine dipstick analysis, the convenience of sample collection compared to blood tests that can cause discomfort and swelling, and the shallow risk of infection due to sample collection can all be related to the significant share of the urine test segment’s rapid growth rate. Renal scintigraphy is one of many imaging tests used to evaluate the kidneys. By Product- Dipsticks, reagents, and disposables make up the market's product categories. The dipsticks segment is predicted to have the most significant kidney function test market share in 2017 and the highest CAGR over the forecast period. Moreover, dipstick testing's cost-effectiveness, which also accounts for its broad application worldwide, is one of the factors contributing to its substantial proportion of the market. By End-Use- The market is divided into hospitals, diagnostics laboratories, and research laboratories and institutes based on end-users. The hospital sector is the market's most significant and fastest-growing segment. In 2020, the hospital sector had the most important market share of 53.89 per cent. This high percentage can be attributable to increased hospital visits as people become more aware of CKD and how to treat it. By Region- North America is expected to have the most significant market share in 2017, followed by Europe. This substantial share can be linked to causes such as the rising incidence of chronic diseases, the increasing prevalence of hypertension, the increasing incidence of diabetes in the United States, and the Canadian government's increasing programs for kidney disease awareness and treatment. However, the Asia Pacific area is expected to have the most incredible CAGR during the projected period. Global Kidney Function Test Market Competitive Landscape Analysis The market is working in terms of competition, and it consists of a lot of significant players in the market. In terms of industry, there are a lot of market players who are dominating the market. UnititMedical Sysmex Corporation Siemens Healthcare GmbH Hoffmann-La Roche Ltd. Randox Laboratories Opti Medical Nova Biomedical Beckman Coulter ARKRAY Inc. Acon Laboratories Abbott Cook Medical 77 Elektronika Medical Care Baxter Boston Scientific Recent Development In Apr 2021, Eurofins Viracor collects acquiescence from the New York State Department of Health Clinical Laboratory Evaluation Program (CLEP) for the Viracor TRAC (Transplant Allograft Rejection Check) TruGraf blood gene expression test and donor-derived cell-free DNA test which help in evaluating the disapproval status in kidney transplant recipients. In Mar 2021, Bio-Techne Corporation launched fundamental pragmatic data on its kidney translucent disapproval test, ExoTRU (Exosome Transplant Rejection Urine), defining that it is efficient in discerning between types of kidney disapproval, supplying condemning data to abet resolution-making and optimizing patient care. Various Product that Key Industry Players Develop Name of the product Function Key Players Dipstick Measuring the depth of a liquid Honeywell, Vega, Hero MotoCorp Ltd. Disposables It decreases the dangers and risks to the communities. .Citiwaste, Sanpro Waste, MedProWaste Disposal Reagents It is used to determine the presence or absence of a specific chemical substance. Agilent Technologies, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., Becton Dickinson & Company Frequently Asked Question About This Report List the essential Players in the market? The most vital players in the market are Unit Medical, Sysmex Corporation, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd., Randox Laboratories, Opti Medical, Nova Biomedical, Beckman Coulter, ARKRAY Inc., Acon Laboratories, Abbott, Cook Medical, 77 Elektronika, Medical Care, Baxter, Boston Scientific. Which is the leading segment among the end-user of the market? Based on the end-user, the ‘Research Laboratories and Institutes’ segment accounted for the highest market share in 2021. List the target audience of the market? These are some of the target audiences of the global market Kidney function test product manufacturers and distributors, Healthcare institutions (hospitals, academic medical centers, and outpatient clinics), Diagnostic laboratories, Health insurance players, Research and consulting firms, Regulatory bodies, Venture capitalists. What are the Kidney function test market growth? The global Kidney function test market is expected to grow at a compound annual growth rate (CAGR) of 6.63 % from 2021 to 2030 to reach USD 1476.53 Million by 2030. How big is the Kidney function test market? The global Kidney function test market size was $ 828.57 Mn in 2021 and is predicted to reach $ 1476.53 Mn by 2030, with a CAGR of 6.63 %. Sources https://connect.medrxiv.org/relate/content/181 https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf https://www.ncqa.org/blog/kidneyhealth/ 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at Market size By bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size By Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Global Kidney Function Test Market 4.2.1 Global Market, 2020 – 2028 (USD Million) 4.3 Regional Analysis 4.3.1 Global Market, By Region, 2021 - 2030 (USD Million) 4.4 By Product Analysis 4.4.1 Global Market, By Product, 2021 - 2030 (USD Million) 4.5 By End-User Analysis 4.5.1 Global Market, By End-User, 2021 - 2030 (USD Million) 4.6 Test Type Analysis 4.6.1 Global Market, By Test Type, 2021 - 2030 (USD Million) 4.7 Value Chain Analysis 4.8 Market Variable Analysis 4.8.1 Market Drivers Analysis 4.8.2 Market Restraints Analysis 4.9 Business Environment Analysis Tool 4.9.1 Market PEST analysis 4.9.2 Market Porter’s analysis 4.10Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Test Type Analysis 5.11.1. Trends in Test Type (2014-2020) 5.11.2. Trends in Test Type (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Manufacturing Sites, Area Served, Product Product 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global Market: By Product Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Dipsticks 7.3.1. Dipsticks Market, 2021 - 2030 (USD Million) 7.4. Reagents 7.4.1. Reagents Market, 2021 - 2030 (USD Million) 7.5. Disposables 7.5.1. Disposables Market, 2021 - 2030 (USD Million) 8. Global Market: By End-User Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Hospitals 8.3.1. Hospitals Market, 2021 - 2030 (USD Million) 8.4. Diagnostic Laboratories 8.4.1. Diagnostic Laboratories Market, 2021 - 2030 (USD Million) 8.5. Research Laboratories and Institutes 8.5.1. Research Laboratories and Institutes Market, 2021 - 2030 (USD Million) 8.6. Others 8.6.1. Others Market, 2021 - 2030 (USD Million) 9. Global Market: By Test Type Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Urine Tests 9.3.1. Urine Tests Market, 2021 - 2030 (USD Million) 9.4. Blood Tests 9.4.1. Blood Tests Market, 2021 - 2030 (USD Million) 10. Global Market: Regional Outlook 10.1 North America 10.1.1. North America Market, By Product, 2021 - 2030 (USD Million) 10.1.2. North America Market, By End-User, 2021 - 2030 (USD Million) 10.1.3. North America Market, By Test Type, 2021 - 2030 (USD Million) 10.1.4. North America Market, By Country, 2021 - 2030 (USD Million) 10.1.4.1. U.S. 10.1.4.1.1. U.S. Market, By Product, 2021 - 2030 (USD Million) 10.1.4.1.2. U.S. Market, By End-User, 2021 - 2030 (USD Million) 10.1.4.1.3. U.S. Market, By Test Type, 2021 - 2030 (USD Million) 10.1.4.2.Canada 10.1.4.2.1. Canada Market, By Product, 2021 - 2030 (USD Million) 10.1.4.2.2. Canada Market, By End-User, 2021 - 2030 (USD Million) 10.1.4.2.3. Canada Market, By Test Type, 2021 - 2030 (USD Million) 10.2. Europe 10.2.1. Europe Market, By Product, 2021 - 2030 (USD Million) 10.2.2. Europe Market, By End-User, 2021 - 2030 (USD Million) 10.2.3. Europe Market, By Test Type, 2021 - 2030 (USD Million) 10.2.4. Europe Market, By country, 2021 - 2030 (USD Million) 10.2.4.1 U.K. 10.2.4.1.1. U.K. Market, By Product, 2021 - 2030 (USD Million) 10.2.4.1.2. U.K. Market, By End-User, 2021 - 2030 (USD Million) 10.2.4.1.3. U.K. Market, By Test Type, 2021 - 2030 (USD Million) 10.2.4.2. Germany 10.2.4.2.1. Germany Market, By Product, 2021 - 2030 (USD Million) 10.2.4.2.2. Germany Market, By End-User, 2021 - 2030 (USD Million) 10.2.4.2.3. Germany Market, By Test Type, 2021 - 2030 (USD Million) 10.2.4.3. France 10.2.4.3.1. France Market, By Product, 2021 - 2030 (USD Million) 10.2.4.3.2. France Market, By End-User, 2021 - 2030 (USD Million) 10.2.4.3.3. France Market, By Test Type, 2021 - 2030 (USD Million) 10.2.4.4. Rest of Europe 10.2.4.4.1. Rest of Europe Market, By Product, 2021 - 2030 (USD Million) 10.2.4.4.2. Rest of Europe Market, By End-User, 2021 - 2030 (USD Million) 10.2.4.4.3. Rest of Europe Market, By Test Type, 2021 - 2030 (USD Million) 10.3. Asia Pacific 10.3.1. Asia Pacific Market, By Product, 2021 - 2030 (USD Million) 10.3.2. Asia Pacific Market, By End-User, 2021 - 2030 (USD Million) 10.3.3. Asia Pacific Market, By Test Type, 2021 - 2030 (USD Million) 10.3.4. Asia Pacific Market, By country, 2021 - 2030 (USD Million) 10.3.4.1. China 10.3.4.1.1. China Market, By Product, 2021 - 2030 (USD Million) 10.3.4.1.2. China Market, By End-User, 2021 - 2030 (USD Million) 10.3.4.1.3. China Market, By Test Type, 2021 - 2030 (USD Million) 10.3.4.2. India 10.3.4.2.1. India Market, By Product, 2021 - 2030 (USD Million) 10.3.4.2.2. India Market, By End-User, 2021 - 2030 (USD Million) 10.3.4.2.3. India Market, By Test Type, 2021 - 2030 (USD Million) 10.3.4.3. Japan 10.3.4.3.1. Japan Market, By Product, 2021 - 2030 (USD Million) 10.3.4.3.2. Japan Market, By End-User, 2021 - 2030 (USD Million) 10.3.4.3.3. Japan Market, By Test Type, 2021 - 2030 (USD Million) 10.3.4.4. South Korea 10.3.4.4.1. South Korea Market, By Product, 2021 - 2030 (USD Million) 10.3.4.4.2. South Korea Market, By End-User, 2021 - 2030 (USD Million) 10.3.4.4.3. South Korea Market, By Test Type, 2021 - 2030 (USD Million) 10.3.4.5. Rest of ASIA PACIFIC 10.3.4.5.1. Rest of ASIA PACIFIC Market, By Product, 2021 - 2030 (USD Million) 10.3.4.5.2. Rest of ASIA PACIFIC Market, By End-User, 2021 - 2030 (USD Million) 10.3.4.5.3. Rest of ASIA PACIFIC Market, By Test Type, 2021 - 2030 (USD Million) 10.4. Latin America 10.4.1. Latin America Market, By Product, 2021 - 2030 (USD Million) 10.4.2. Latin America Market, By End-User, 2021 - 2030 (USD Million) 10.4.3. Latin America Market, By Test Type, 2021 - 2030 (USD Million) 10.4.4. Latin America Market, By country, 2021 - 2030 (USD Million) 10.4.4.1. Brazil 10.4.4.1.1. Brazil Market, By Product, 2021 - 2030 (USD Million) 10.4.4.1.2. Brazil Market, By End-User, 2021 - 2030 (USD Million) 10.4.4.1.3. Brazil Market, By Test Type, 2021 - 2030 (USD Million) 10.4.4.2. Mexico 10.4.4.2.1. Mexico Market, By Product, 2021 - 2030 (USD Million) 10.4.4.2.2. Mexico Market, By End-User, 2021 - 2030 (USD Million) 10.4.4.2.3. Mexico Market, By Test Type, 2021 - 2030 (USD Million) 10.4.4.3. Rest of the Latin America 10.4.4.3.1. Rest of the Latin America Market, By Product, 2021 - 2030 (USD Million) 10.4.4.3.2. Rest of the Latin America Market, By End-User, 2021 - 2030 (USD Million) 10.4.4.3.3. Rest of the Latin America Market, By Test Type, 2021 - 2030 (USD Million) 10.5. MEA 10.5.1. MEA Market, By Product, 2021 - 2030 (USD Million) 10.5.2. MEA Market, By End-User, 2021 - 2030 (USD Million) 10.5.3. MEA Market, By Test Type, 2021 - 2030 (USD Million) 10.5.4. MEA Market, By Region, 2021 - 2030 (USD Million) 11. Competitive Landscape 11.1 Unitit Medical 11.1.1. Company overview 11.1.2. Financial performance 11.1.3. ProductPortfolio Analysis 11.1.4. Business Strategy & Recent Development 11.2. SYSMEX CORPORATION 11.2.1. Company overview 11.2.2. Financial performance 11.2.3. Product Portfolio Analysis 11.2.4. Business Strategy & Recent Development 11.3. SIEMENS HEALTHCARE GMBH 11.3.1. Company overview 11.3.2. Financial performance 11.3.3. Product Portfolio Analysis 11.3.4. Business Strategy & Recent Development 11.4. F. HOFFMANN-LA ROCHE LTD. 11.4.1. Company overview 11.4.2. Financial performance 11.4.3. Product Portfolio Analysis 11.4.4. Business Strategy & Recent Development 11.5. RANDOX LABORATORIES 11.5.1. Company overview 11.5.2. Financial performance 11.5.3. Product Portfolio Analysis 11.5.4. Business Strategy & Recent Development 11.6. Opti Medical 11.6.1. Company overview 11.6.2. Financial performance 11.6.3. Product Portfolio Analysis 11.6.4. Business Strategy & Recent Development 11.7. Nova Biomedical 11.7.1. Company overview 11.7.2. Financial performance 11.7.3. Product Portfolio Analysis 11.7.4. Business Strategy & Recent Development 11.8. Beckman Coulter. 11.8.1. Company overview 11.8.2. Financial performance 11.8.3. Product Portfolio Analysis 11.8.4. Business Strategy & Recent Development 11.9. ARKRAY Inc. 11.9.1. Company overview 11.9.2. Financial performance 11.9.3. Product Portfolio Analysis 11.9.4. Business Strategy & Recent Development 11.10. Acon Laboratories 11.10.1. Company overview 11.10.2. Financial performance 11.10.3. Product Portfolio Analysis 11.10.4. Business Strategy & Recent Development 11.11. Abbott 11.11.1. Company overview 11.11.2. Financial performance 11.11.3. Product Portfolio Analysis 11.11.4. Business Strategy & Recent Development 11.12. Cook Medical. 11.12.1. Company overview 11.12.2. Financial performance 11.12.3. Product Portfolio Analysis 11.12.4. Business Strategy & Recent Development 11.13. 77 Elektronika 11.13.1. Company overview 11.13.2. Financial performance 11.13.3. Product Portfolio Analysis 11.13.4. Business Strategy & Recent Development 11.14. Medical Care 11.14.1. Company overview 11.14.2. Financial performance 11.14.3. Product Portfolio Analysis 11.14.4. Business Strategy & Recent Development 11.15. Baxter 11.15.1. Company overview 11.15.2. Financial performance 11.15.3. Product Portfolio Analysis 11.15.4. Business Strategy & Recent Development 11.16. Boston Scientific 11.15.1. Company overview 11.15.2. Financial performance 11.15.3. Product Portfolio Analysis 11.15.4. Business Strategy & Recent Development List of Tables (66 Tables) TABLE 1. MARKET, By Product, 2021-2030 (USD Million) TABLE 2. MARKET FOR Dipsticks, BY REGION, 2021-2030 (USD Million) TABLE 3. MARKET FOR Reagents, BY REGION, 2021-2030 (USD Million) TABLE 4. MARKET FOR Disposables, BY REGION, 2021-2030 (USD Million) TABLE 5. MARKET, By End-User, 2021-2030 (USD Million) TABLE 6. MARKET FOR Hospitals, BY REGION, 2021-2030 (USD Million) TABLE 7. MARKET FOR Diagnostic Laboratories, BY REGION, 2021-2030 (USD Million) TABLE 8. MARKET FOR Research Laboratories and Institutes , BY REGION, 2021-2030 (USD Million) TABLE 9. MARKET FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 11. MARKET, BY TEST TYPE, 2021-2030 (USD Million) TABLE 12. MARKET FOR Urine Tests , BY REGION, 2021-2030 (USD Million) TABLE 13. MARKET FOR Blood Tests , BY REGION, 2021-2030 (USD Million) TABLE 18. MARKET, BY REGION, 2021-2030 (USD Million) TABLE 19. NORTH AMERICA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 20. NORTH AMERICA MARKET, By Product, 2021-2030 (USD Million) TABLE 21. NORTH AMERICA MARKET, By End-User, 2021-2030 (USD Million) TABLE 22. NORTH AMERICA MARKET, BY TEST TYPE, 2021-2030 (USD Million) TABLE 23. EUROPE MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 24. EUROPE MARKET, By Product, 2021-2030 (USD Million) TABLE 25. EUROPE MARKET, By End-User, 2021-2030 (USD Million) TABLE 26. EUROPE MARKET, BY TEST TYPE, 2021-2030 (USD Million) TABLE 27. ASIA-PACIFIC MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 28. ASIA-PACIFIC MARKET, By Product, 2021-2030 (USD Million) TABLE 29. ASIA-PACIFIC MARKET, By End-User, 2021-2030 (USD Million) TABLE 30. ASIA-PACIFIC MARKET, BY TEST TYPE, 2021-2030 (USD Million) TABLE 31. LAMEA MARKET, BY COUNTRY, 2021-2030 (USD Million) TABLE 32. LAMEA MARKET, By Product, 2021-2030 (USD Million) TABLE 33. LAMEA MARKET, By End-User, 2021-2030 (USD Million) TABLE 34. LAMEA MARKET, BY TEST TYPE, 2021-2030 (USD Million) TABLE 35. UnititMedical: COMPANY SNAPSHOT TABLE 36. UnititMedical: OPERATING SEGMENTS TABLE 37. SYSMEX CORPORATION: COMPANY SNAPSHOT TABLE 38. SYSMEX CORPORATION: OPERATING SEGMENTS TABLE 39. SIEMENS HEALTHCARE GMBH: COMPANY SNAPSHOT TABLE 40. SIEMENS HEALTHCARE GMBH: OPERATING SEGMENTS TABLE 41. F. HOFFMANN-LA ROCHE LTD. : COMPANY SNAPSHOT TABLE 42. F. HOFFMANN-LA ROCHE LTD. : OPERATING SEGMENTS TABLE 43. RANDOX LABORATORIES: COMPANY SNAPSHOT TABLE 44. RANDOX LABORATORIES: OPERATING SEGMENTS TABLE 45. Opti Medical: COMPANY SNAPSHOT TABLE 46. Opti Medical: OPERATING SEGMENTS TABLE 47. Nova Biomedical: COMPANY SNAPSHOT TABLE 48. Nova Biomedical: OPERATING SEGMENTS TABLE 49. Beckman Coulter: COMPANY SNAPSHOT TABLE 50. Beckman Coulter: OPERATING SEGMENTS TABLE 51. ARKRAY Inc.: COMPANY SNAPSHOT TABLE 52. ARKRAY Inc.: OPERATING SEGMENTS TABLE 53. Acon Laboratories: COMPANY SNAPSHOT TABLE 54. Acon Laboratories: OPERATING SEGMENTS TABLE 55. Abbott: COMPANY SNAPSHOT TABLE 56. Abbott: OPERATING SEGMENTS TABLE 57. Cook Medical: COMPANY SNAPSHOT TABLE 58. Cook Medical: OPERATING SEGMENTS TABLE 59. 77 Elektronika: COMPANY SNAPSHOT TABLE 60. 77 Elektronika: OPERATING SEGMENTS TABLE 61. Medical Care: COMPANY SNAPSHOT TABLE 62. Medical Care: OPERATING SEGMENTS TABLE 63. Baxter: COMPANY SNAPSHOT TABLE 64. Baxter: OPERATING SEGMENTS TABLE 65. Boston Scientific: COMPANY SNAPSHOT TABLE 66. Boston Scientific: OPERATING SEGMENTS List of Figures (22 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Product-Based Estimation Figure 6 Top 16 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Kidney Function Test, By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for Kidney Function Test, By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By End-User, 2019 vs. 2025 (USD Million) Figure 12 Market Share, By Test Type, 2019 vs. 2025 (USD Million) Figure 13 Market Share, By Product, 2019 vs. 2025 (USD Million) Figure 14 Geographical Snapshot of the Market Figure 15 Dipsticks to Witness Higher CAGR in Market for Product Segment during Forecast Period. Figure 16 Urine Tests to Witness Higher CAGR in Market for Test Type Segment during Forecast Period. Figure 17 Hospitals to Witness Higher CAGR in Market for End-User Segment during Forecast Period. Figure 18 North America region Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 19 Market: Drivers, Restraints, Opportunities, and Challenges Figure 20 North America: Market Snapshot Figure 21 Asia Pacific: Market Snapshot Figure 22 Vendor Dive: Evaluation Overview